人类胃肠道微生物群与前列腺癌的发生发展及治疗。
The human gastrointestinal microbiota and prostate cancer development and treatment.
机构信息
Dartmouth Medical School, Hanover, NH, USA.
University of Central Florida, Orlando, FL, USA.
出版信息
Investig Clin Urol. 2020 Feb;61(Suppl 1):S43-S50. doi: 10.4111/icu.2020.61.S1.S43. Epub 2019 Sep 24.
Abstract
The human gastrointestinal microbiome contains commensal bacteria and other microbiota that have been gaining increasing attention in the context of cancer development and response to treatment. Microbiota play a role in the maintenance of host barrier surfaces that contribute to both local inflammation and other systemic metabolic functions. In the context of prostate cancer, the gastrointestinal microbiome may play a role through metabolism of estrogen, an increase of which has been linked to the induction of prostatic neoplasia. Specific microbiota such as , , , , , and have been associated with differing risks of prostate cancer development or extensiveness of prostate cancer disease. In this Review, we discuss gastrointestinal microbiota's effects on prostate cancer development, the ability of the microbiome to regulate chemotherapy for prostate cancer treatment, and the importance of using Next Generation Sequencing to further discern the microbiome's systemic influence on prostate cancer.
摘要
人类胃肠道微生物组包含共生细菌和其他微生物群，这些微生物群在癌症的发生和对治疗的反应中越来越受到关注。微生物群在维持宿主屏障表面方面发挥作用，这些表面有助于局部炎症和其他全身代谢功能。在前列腺癌的背景下，胃肠道微生物组可能通过代谢雌激素发挥作用，雌激素的增加与前列腺肿瘤的诱导有关。特定的微生物群，如 、 、 、 、 和 ，与前列腺癌发展的不同风险或前列腺癌疾病的广泛程度有关。在这篇综述中，我们讨论了胃肠道微生物群对前列腺癌发展的影响、微生物群调节前列腺癌治疗化疗的能力，以及使用下一代测序进一步辨别微生物群对前列腺癌的系统影响的重要性。
相似文献
1
The human gastrointestinal microbiota and prostate cancer development and treatment.人类胃肠道微生物群与前列腺癌的发生发展及治疗。
Investig Clin Urol. 2020 Feb;61(Suppl 1):S43-S50. doi: 10.4111/icu.2020.61.S1.S43. Epub 2019 Sep 24.
2
From microbes to medicine: harnessing the gut microbiota to combat prostate cancer.从微生物到医学：利用肠道微生物群对抗前列腺癌。
Microb Cell. 2024 May 23;11:187-197. doi: 10.15698/mic2024.05.824. eCollection 2024.
3
The microbiome in prostate inflammation and prostate cancer.前列腺炎症和前列腺癌中的微生物组。
Prostate Cancer Prostatic Dis. 2018 Sep;21(3):345-354. doi: 10.1038/s41391-018-0041-1. Epub 2018 May 23.
4
The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study.肠道微生物群在前列腺癌发病机制中的作用：一项前瞻性试点研究。
Urology. 2018 Jan;111:122-128. doi: 10.1016/j.urology.2017.08.039. Epub 2017 Sep 6.
5
The Microbiome and Prostate Cancer Risk.微生物组与前列腺癌风险。
Curr Urol Rep. 2019 Sep 7;20(10):66. doi: 10.1007/s11934-019-0922-4.
6
Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment.微生物组与前列腺癌：预防和治疗的新靶点。
Int J Mol Sci. 2023 Jan 12;24(2):1511. doi: 10.3390/ijms24021511.
7
Human microbiome and prostate cancer development: current insights into the prevention and treatment.人类微生物组与前列腺癌的发生发展：预防和治疗的最新研究进展。
Front Med. 2021 Feb;15(1):11-32. doi: 10.1007/s11684-019-0731-7. Epub 2020 Jun 30.
8
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
9
The Human Microbiome and Cancer.人类微生物组与癌症
Cancer Prev Res (Phila). 2017 Apr;10(4):226-234. doi: 10.1158/1940-6207.CAPR-16-0249. Epub 2017 Jan 17.
10
Action and function of Faecalibacterium prausnitzii in health and disease.普拉梭菌在健康与疾病中的作用和功能。
Best Pract Res Clin Gastroenterol. 2017 Dec;31(6):643-648. doi: 10.1016/j.bpg.2017.09.011. Epub 2017 Sep 18.
引用本文的文献
1
Advancing prostate cancer treatment: the role of fecal microbiota transplantation as an adjuvant therapy.推进前列腺癌治疗：粪便微生物群移植作为辅助治疗的作用。
Curr Res Microb Sci. 2025 Jun 11;9:100420. doi: 10.1016/j.crmicr.2025.100420. eCollection 2025.
2
Microbiome in prostate cancer: pathogenic mechanisms, multi-omics diagnostics, and synergistic therapies.前列腺癌中的微生物组：致病机制、多组学诊断及协同治疗
J Cancer Res Clin Oncol. 2025 May 31;151(6):178. doi: 10.1007/s00432-025-06187-w.
3
Therapeutic potential of microbiome modulation in reproductive cancers.微生物群调节在生殖系统癌症中的治疗潜力
Med Oncol. 2025 Apr 6;42(5):152. doi: 10.1007/s12032-025-02708-2.
4
Synergistic Effects of Probiotics and Lifestyle Interventions on Intestinal Microbiota Composition and Clinical Outcomes in Obese Adults.益生菌与生活方式干预对肥胖成年人肠道微生物群组成及临床结局的协同作用
Metabolites. 2025 Jan 23;15(2):70. doi: 10.3390/metabo15020070.
5
PTTM: dissecting the profile of tumor tissue microbiome to reveal microbiota features and associations with host transcriptome.肺肿瘤血栓性微血管病：剖析肿瘤组织微生物组特征以揭示微生物群特征及其与宿主转录组的关联
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbaf057.
6
Causal roles of dietary structure and types on prostate cancer risk: A mendelian randomization study.膳食结构和类型对前列腺癌风险的因果作用：一项孟德尔随机化研究。
BMC Cancer. 2024 Nov 29;24(1):1476. doi: 10.1186/s12885-024-13252-z.
7
Screening of promising molecules against potential drug targets in Yersinia pestis by integrative pan and subtractive genomics, docking and simulation approach.综合泛基因组学和消减基因组学、对接和模拟方法筛选对鼠疫耶尔森氏菌潜在药物靶点有前景的分子。
Arch Microbiol. 2024 Sep 25;206(10):415. doi: 10.1007/s00203-024-04140-y.
8
The Microbiota in Cancer: A Secondary Player or a Protagonist?癌症中的微生物群：配角还是主角？
Curr Issues Mol Biol. 2024 Jul 23;46(8):7812-7831. doi: 10.3390/cimb46080463.
9
Analysis of factors associated with positive surgical margins and the five-year survival rate after prostate cancer resection and predictive modeling.前列腺癌切除术后切缘阳性及五年生存率相关因素分析与预测模型
Front Oncol. 2024 Jun 6;14:1360404. doi: 10.3389/fonc.2024.1360404. eCollection 2024.
10
Impact of fast-track surgery-oriented care pathways on perioperative rehabilitation indices in patients undergoing radical prostatectomy for prostate cancer.以快速康复外科为导向的护理路径对前列腺癌根治术患者围手术期康复指标的影响。
Am J Transl Res. 2024 May 15;16(5):1620-1629. doi: 10.62347/ZMUX1738. eCollection 2024.
本文引用的文献
1
Microbiome and Cancers, With Focus on Genitourinary Tumors.微生物组与癌症，重点关注泌尿生殖系统肿瘤
Front Oncol. 2019 Mar 26;9:178. doi: 10.3389/fonc.2019.00178. eCollection 2019.
2
Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors.抗生素与接受免疫检查点抑制剂治疗的晚期黑色素瘤患者无进展生存期缩短有关。
Oncoimmunology. 2019 Feb 18;8(4):e1568812. doi: 10.1080/2162402X.2019.1568812. eCollection 2019.
3
Infection and Chronic Inflammation in Human Prostate Cancer: Detection Using Prostatectomy and Needle Biopsy Specimens.人前列腺癌中的感染和慢性炎症：使用前列腺切除术和针吸活检标本进行检测。
Cells. 2019 Mar 2;8(3):212. doi: 10.3390/cells8030212.
4
Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.微生物学、分子病理学和流行病学的整合：探索微生物组驱动型肿瘤发病机制的新模式。
J Pathol. 2019 Apr;247(5):615-628. doi: 10.1002/path.5236. Epub 2019 Feb 20.
5
Cancer statistics, 2019.癌症统计数据，2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
6
Gut Microbiota and Cancer: From Pathogenesis to Therapy.肠道微生物群与癌症：从发病机制到治疗
Cancers (Basel). 2019 Jan 3;11(1):38. doi: 10.3390/cancers11010038.
7
A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysis.一项前瞻性研究，通过16sRNA基因分析来检测经直肠前列腺活检后前列腺癌诊断与尿液和粪便微生物群之间的关联。
Prostate. 2019 Jan;79(1):81-87. doi: 10.1002/pros.23713. Epub 2018 Aug 16.
8
Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer.从与前列腺癌相关的粪便微生物组中鉴定出的代谢生物合成途径。
Eur Urol. 2018 Nov;74(5):575-582. doi: 10.1016/j.eururo.2018.06.033. Epub 2018 Jul 12.
9
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies.雄激素轴靶向治疗前列腺癌患者胃肠道微生物群落组成的差异。
Prostate Cancer Prostatic Dis. 2018 Nov;21(4):539-548. doi: 10.1038/s41391-018-0061-x. Epub 2018 Jul 9.
10
An implementation of next generation sequencing for prevention and diagnosis of urinary tract infection in urology.下一代测序技术在泌尿外科预防和诊断尿路感染中的应用
Can J Urol. 2018 Jun;25(3):9349-9356.
Zotero 插件